Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine and arginine rich splicing factor 8B, pseudogene (SRSF8BP) is annotated as a pseudogene in gene databases. Pseudogenes are DNA segments similar to known genes but considered nonfunctional due to accumulated mutations, lack of transcription, or inability to encode a functional protein. They can sometimes interfere with laboratory assays or complicate genomic analyses by sequence similarity but do not function as drug targets or encode activities relevant to therapeutic targeting[1][4]. There is no evidence that SRSF8BP produces a functional RNA or protein, nor any known role in human disease or pharmacology. As such, it is not a relevant entity for therapeutic development, target validation, or clinical biomarker use[1][4]. If you require information about the functional gene family (serine/arginine-rich splicing factors), many functional protein-coding members exist (such as SRSF8), but the "-pseudogene" form is specifically not a bona fide protein-coding target.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine and arginine rich splicing factor 8B, pseudogene (SRSF8BP).